China Resources Pharmaceutical Group Limited (03320) has announced the interim financial results of its subsidiary, Dong-E-E-Jiao Co., Ltd., for the six months ended June 30, 2026.

The subsidiary recorded total operating revenue of RMB 3.155 billion, representing a year-on-year increase of 3.39%. Net profit attributable to shareholders of the listed company reached RMB 860 million, up 5.66% compared to the same period last year. Basic earnings per share stood at RMB 1.34.